Rick Helmich, researcher at the Donders Center for Medical Neurosciences, receives a grant of $ 693,000 from the Michael J Fox Foundation. With this he can investigate the brain mechanisms that are responsible for the progression of Parkinson's disease. In theresearch He uses the data collected in the Personalized Parkinson Project.
To this end, they will make use of the data from the Personalized Parkinson Project (led by Bas Bloem), which is a longitudinal study in 650 Parkinson patients who will receive brain scans at baseline and after a followup of 2 years.). For the project, they will use half of this population (n=325), who will perform a motor task in the fMRI scanner at both time points. The task is optimized to detect dysfunctional activity in the basal ganglia, and compensatory activity in cortical regions (parietal cortex). They will relate changes in activity on both regions to clinical disease progression.
If they show that disease progression is mainly caused by changes in compensatory activity (rather than dysfunctional activity in the basal ganglia), then this may shift the treatment focus from cells that are gone (dopamine depletion) to cells that survive (compensation).
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

Grants for science communication at Radboudumc
22 April 2021 Scientists at the Radboudumc have received two KNAW grants, each worth 10,000 euros, for science communication. With the new fund, KNAW underlines importance of making science accessible. read more
UMD Catalist grant for Mohammad Alsady and Federica Conte
24 June 2020They received this award to explore the potential of hiPS-derived skeletal muscle cells as model to investigate muscular pathophysiologic mechanisms in phosphoglucomutase I deficiency.
read more
Bas Bloem elected as new member of the KNAW
30 April 2020 Bas Bloem is an expert in Parkinson's disease. He is also a healthcare innovator, focused on the integration of scientific research and its clinical applications. We congratulate Bas with this election. read more
KNAW Van Leersum beurs for Mohammad Alsady
7 November 2019 Mohammad Alsady, theme Disorders of movement, received the “KNAW Van Leersum beurs”. read more
Towards molecular therapies for Myotonic Dystrophy
1 October 2019ReCognitION, a new 1.3 M€ European project under the leadership of Peter-Bram ‘t Hoen, Baziel van Engelen and Jeffrey Glennon, was kicked-off in Gent.
read more